Paloma Health

Investor: Triple Point Ventures

Paloma Health, a London-based healthtech startup, has successfully secured £2 million in Pre-Seed funding. This investment, spearheaded by Triple Point Ventures with support from Heal Capital and angel investors, will be used to enhance NHS health services through AI, specifically targeting reduced wait times for critical assessments like autism.Summary of transaction details:Value: £2,000,000Sector: HealthtechAdvisor: N/AKey Entities: Paloma Health (Target), Triple Point Ventures (Lead Investor), Heal Capital, Pam Garside, James Allgrove (Investors)Location: London, UK (Target)Note: This Pre-Seed funding round highlights investor confidence in Paloma Health's innovative approach to leveraging artificial intelligence to address critical bottlenecks within the NHS, aiming to improve accessibility and efficiency for patients and clinicians alike.